Mylan has set its sights on bringing generic versions of three top-selling insulin brands to market. The company has signed a collaboration deal with Biocon to develop and commercialise the Indian ...
Last week, Eli Lilly announced it was introducing a lower-priced authorized generic - a repackaged version of the brand - of its rapidly acting insulin lispro injection (Humalog) in the U.S.. The ...
Mylan has entered into a definitive agreement with Biocon Limited for an exclusive collaboration on the development and commercialization of generic versions of three insulin analog products. Mylan ...
PRINCETON, N.J. Novo Nordisk has received approval from the Food and Drug Administration for its insulin drug NovoLog to be used in external, subcutaneous insulin pumps by children and adolescents ...
People with diabetes were notified the other day by insurance giant UnitedHealthcare that one of the most widely prescribed insulins, NovoLog, is switching from the company's Tier 1 drug list to Tier ...
Adocia has launched a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog®, Eli Lilly) using its proprietary technology BioChaperone®). This clinical trial aims to ...
WILMINGTON, N.C. (WECT) - A nationwide insulin shortage has been affecting millions of people for over a month now. Companies say they’re getting back on track after some supply chain issues, but some ...
What about that diabetes price war? When Sanofi ($SNY) announced that its franchise would suffer next year because of U.S. payer contracts, that was the natural ...
(Reuters) - Eli Lilly and Co's quarterly results were badly hurt by disappointing sales of its Humalog insulin and animal health products, but the company on Tuesday reaffirmed its full-year earnings ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback